Anticoagulant and antiplatelet combined therapy in patients 75 years and over with atrial fibrillation: a prospective observational study assessing adherence to clinical guidelines.

European Journal of Hospital Pharmacy. Science and Practice
Anaïs MinaryThomas Vogel

Abstract

According to current guidelines on atrial fibrillation (AF), the addition of an antiplatelet therapy to an anticoagulant for a stable vascular disease does not decrease the ischaemic hazard but increases the risk of bleeding. The aim of the study was to assess compliance of practices with existing clinical guidelines concerning the use of anticoagulant-antiplatelet combined therapy in patients 75 years and over with AF. This prospective observational study was carried out at the University Hospital of Strasbourg (France) between August 2016 and January 2017 with data collection on 1 day of every month. To be included, the patient had to be 75 years and over with AF and treated with anticoagulant-antiplatelet therapy. The population included all the patients admitted at the hospital excluding those from the Gynaecology-Obstetrics and Paediatrics departments. With regard to clinical ongoing guidelines (French, European, American and Canadian), the patients were sorted into three groups. Group 1: combined therapy in compliance with recommendations; Group 2: combined therapy debatable as to benefit-risk ratio; and Group 3: combined therapy not compliant with recommendations. Ninety-three out of 3307 patients 75 years and over recei...Continue Reading

References

Aug 28, 2004·Stroke; a Journal of Cerebral Circulation·Theresa I ShiremanEdward F Ellerbeck
Dec 9, 2008·American Heart Journal·Shinya GotoUNKNOWN REACH Registry Investigators
May 3, 2014·Stroke; a Journal of Cerebral Circulation·Walter N KernanUNKNOWN American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and
Aug 1, 2014·Pharmacoepidemiology and Drug Safety·Charles HengBruno Michel
Sep 10, 2016·The Canadian Journal of Cardiology·Laurent MacleUNKNOWN CCS Atrial Fibrillation Guidelines Committee
Sep 25, 2016·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Paulus KirchhofKatja Zeppenfeld
Oct 7, 2017·BMJ : British Medical Journal·Christopher N Floyd, Albert Ferro

❮ Previous
Next ❯

Citations

Jul 29, 2021·European Journal of Clinical Pharmacology·Renate C A E van UdenMatthijs L Becker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Internal and Emergency Medicine
Maria Cristina VedovatiGiancarlo Agnelli
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society
F DettoniR Rossi
Giornale italiano di cardiologia : organo ufficiale della Federazione italiana di cardiologia : organo ufficiale della Società italiana di chirurgia cardiaca
Marco TubaroFurio Colivicchi
© 2021 Meta ULC. All rights reserved